JNJ Textbook Ascending TriangleThis is a textbook ascending triangle. Watch for the reaction next time it tests resistance or support.by StocksAndStonesUpdated 3
This is getting interestingThis is looking overbought, but check out the pattern forming, and consider the recent 20/200 ma crossover, and apparently a 50/200 ma crossover is imminent!Longby Ron-V117
JNJ reversed from resistance, potential drop! JNJ reversed off its resistance at 141.36 where it could potentially drop further to 133.94. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets5
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 141.15 where it could potentially react off and drop down to 1st support at 133.94. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets5
JNJ approaching resistance, look out for potential reversal! JNJ is approaching its resistance at 139.29 where it is could reverse down to its support at 132.90. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets3
JNJ approaching resistance, look out for potential reversal! JNJ is approaching its resistance at 139.29 where it is could reverse down to its support at 132.90. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets3
JNJ approaching resistance, look out for potential reversal! JNJ is approaching its resistance at 139.29 where it is could reverse down to its support at 132.90. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets8
JNJ - WEEK CHARTHi, today we are going to talk about Johnson & Johnson and its current landscape. The opioid crisis has been plaguing the U.S at the most for nearly two years now. With scary numbers like the record of 47,600* overdose deaths caused by opioids in 2017 but the number seems to start slowdown since 2018 were the war against opioids gained some traction. In the justice field, some companies have already faced some sort of rebuke for involvement and even a bit of responsibility for the opioid crisis. For example *Jun 2019, Insys Therapeutics Inc. had to file for bankruptcy after being convicted for conspiring to bribe doctors to increase opioid sales, ending up in a deal with the federal government of $225 million. * Aug 2019, Johnson & Johnson was obligated to pay $572 Million, as Oklahoma ruled that the company intentionally played down the dangers and oversold the benefits of opioids. * Oct 2019, Johnson & Johnson was once more condemned by two counties of Ohio to pay $20.4 million, with the accusation of having helped the opioid crisis to spread. Now, the drug maker Johnson & Johnson is under investigation by the Federal Prosecutors in Brooklyn, into whether the company intentionally permitted that flood of opioids on the community. For now the U.S. Attorney’s Office in the Eastern District of New York it's just issuing subpoenas, but if they case sticks we might see what the murders of Julius Caesar saw, a pile of fire and anger from the people, so big that like Caesar butchers that were cast out of the city, the companies involved on this process can be drowned in liabilities and fines with the risk to be so badly damaged that may have the same fate of Insys Therapeutics Inc. The war against opioids it's just poised to grow up as every justice department across the country and every candidate that it's next to run on elections its eager to hang this trophy on the wall. *Source: Centers for Disease Control and Prevention (CDC) Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice. by Igor-Silva2227
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 139.29 where it could potentially react off and drop down to 1st support at 132.90. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets2
JNJ bullish breakout confirmed JNJ broke its 200sma this Wednesday, November 20th. *For more technical analysis information on this event, check in "related ideas" or click here: There was a short-term resistance as the trade range was still inside the triangle (check chart). Currently being broken Longby dorfmanmaster4
JNJ approaching resistance, look out for potential reversal! JNJ is approaching its resistance at 137.31 where it is could reverse down to its support at 130.54. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets2
Johnson & Johnson - Healthcare outperformingJNJ has breached its 200sma resistance, to enter "channel 1". I would wait 2-3 closes inside the channel above the 200sma to enter a position. Profit-exit ---> $144.2 Stop-loss ---> $133.19 Approximate RRR ---> 3:1 Longby dorfmanmaster4
JNJ reversed from resistance, potential drop! JNJ reversed off its resistance at 137.31 where it could potentially drop further to 130.54. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets1
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 137.31 where it could potentially react off and drop down to 1st support at 130.54. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets2
JNJ potential reversal! JNJ expected to rise up to 1st resistance at 137.31 where it could potentially react off and drop down to 1st support at 130.54. Trading CFDs on margin carries high risk. Losses can exceed the initial investment so please ensure you fully understand the risks. Shortby easyMarkets1